المؤلفون: Krol, AD, Hermans, J, Dawson, L, Snijder, S, Wijermans, PW, Kluin-Nelemans, JC, Kluin, PM, van Krieken, JHJM, Noordijk, EM

المساهمون: Radiation Oncology

المصدر: Cancer, 83, 1612-1619. John Wiley & Sons Inc.

مصطلحات موضوعية: SDG 3 - Good Health and Well-being

URL الوصول: https://explore.openaire.eu/search/publication?articleId=narcis______::787ef6e35c9edb20f43c1da1ffb6acae
https://pure.eur.nl/en/publications/be148dd4-6cff-477f-b4ac-1f4cd06403d8

المؤلفون: de Vries S, Schaapveld M, Kardaun JWPF, de Bruin KH, Krol ADG, Lugtenburg PJ, Jacobse JN, Aleman BMP, van Leeuwen FE

المصدر: Clinical Epidemiology, Vol Volume 10, Pp 1523-1531 (2018)

مصطلحات موضوعية: Cause of death, Hodgkin lymphoma, Breast cancer, Mortality statistics, Infectious and parasitic diseases, RC109-216

وصف الملف: electronic resource

Relation: https://www.dovepress.com/comparing-causes-of-death-of-hodgkin-lymphoma-and-breast-cancer-patien-peer-reviewed-article-CLEP; https://doaj.org/toc/1179-1349

URL الوصول: https://doaj.org/article/75c958ab415d4243a0059ed5d9d4bbce

المؤلفون: Gelderblom H, Hogendoorn PCW, Dijkstra SD, van Rijswijk CS, Krol AD, Taminiau AHM, Bovée JVM

المصدر: Oncologist; Mar2008, Vol. 13 Issue 3, p320-329, 10p

المؤلفون: Hermans, J, Krol, AD, van Groningen, K, Kluin, PM, Kluin-Nelemans, JC, Kramer, MH, Noordijk, EM, Ong, F, Wijermans, PW

المصدر: Blood; August 1995, Vol. 86 Issue: 4 p1460-1463, 4p

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Moojen WA, Vleggeert-Lankamp CL, Krol AD, Dijkstra SP

المصدر: Spine (03622436); 5/1/2011, Vol. 36 Issue 10, pE656-61, 1p

المؤلفون: Palubeckaitė I; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands., Venneker S; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands., Briaire-de Bruijn IH; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands., van den Akker BE; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands., Krol AD; Department of Radiation Oncology, Leiden University Medical Center, Leiden, Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands., Bovée JVMG; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands.

المصدر: Frontiers in molecular biosciences [Front Mol Biosci] 2020 Dec 21; Vol. 7, pp. 566291. Date of Electronic Publication: 2020 Dec 21 (Print Publication: 2020).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101653173 Publication Model: eCollection Cited Medium: Print ISSN: 2296-889X (Print) Linking ISSN: 2296889X NLM ISO Abbreviation: Front Mol Biosci Subsets: PubMed not MEDLINE

المؤلفون: Radaelli S; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: stefano.radaelli@istitutotumori.mi.it., Fossati P; MedAustron Ion Therapy Center, Wiener Neustadt, Austria., Stacchiotti S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy., Akiyama T; Department of Orthopeadic Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Japan., Asencio JM; General Surgery III Department and Liver Transplant Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Bandiera S; Department of Oncologic and Degenerative Spine Surgery, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy., Boglione A; Medical Oncology Unit, Ospedale Humanitas, Gradenigo, Torino, Italy., Boland P; Orthopedic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA., Bolle S; Département de Radiothérapie, Gustave-Roussy Cancer Campus, Villejuif, France., Bruland Ø; University of Oslo, Institute for Clinical Medicine and Department of Oncology, Oslo University Hospital-Norwegian Radium Hospital, Oslo, Norway., Brunello A; Department of Clinical and Experimental Oncology, Medical Oncology 1st Unit, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy., Bruzzi P; Dipartimento di Epidemiologia Clinica, IRCCS, AOU San Martino - IST, Genova, Italy., Campanacci D; Department of Orthopedic Oncology, Azienda Ospedaliero Universitaria Careggi, Firenze, Toscana, Italy., Cananzi F; Surgical Oncology Unit - Humanitas Clinical and Research Center, Rozzano, Italy., Capanna R; 1st Orthopedic Division of Pisa University, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Casadei R; Department of Orthopedics, Istituto Ortopedico Rizzoli, University of Bologna, Bologna, Italy., Cordoba A; Department of Radiotherapy, Oscar Lambret Comprehensive Cancer Center, Lille, France., Court C; Orthopaedic and Traumatology Department, Spine and Tumor Unit, Bicetre University Hospital, AP-HP Paris, Univ. Paris-Sud Orsay, France., Dei Tos AP; Department of Pathology and Molecular Genetics, Treviso General Hospital, Treviso, Italy; Department of Medicine, University of Padova School of Medicine, Padova, Italy., DeLaney TF; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA., De Paoli A; Department of Radiation Oncology, Centro di Riferimento Oncologico, National Cancer Institute, Aviano, Italy., De Pas TM; Division of Medical Oncology for Melanoma & Sarcoma, IEO, European Institute of Oncology IRCCS, Milan, Italy., Desai A; Department of Sarcoma and General Surgery, Midlands Abdominal and Retroperitoneal Sarcoma Unit, University Hospital Birmingham, NHS Foundation Trust, Birmingham, UK., Di Brina L; Radiotherapy and Radiosurgery, Humanitas Clinical and Research Center, Rozzano, Milano, Italy., Donati DM; Department of Orthopedics, Istituto Ortopedico Rizzoli, University of Bologna, Bologna, Italy., Fabbri N; Orthopedic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA., Fiore MR; Radiotherapy Unit, National Center of Oncological Hadrontherapy (CNAO) Pavia, Italy., Frezza A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy., Gambarotti M; Department of Pathology, IRCCS Rizzoli Orthopaedic Institute, Bologna, Italy., Gasbarrini A; Department of Oncologic and Degenerative Spine Surgery, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy., Georg P; MedAustron Ion Therapy Center, Wiener Neustadt, Austria., Grignani G; Medical Oncology-Sarcoma Unit, Istituto di Candiolo-Fondazione del Piemonte per L'Oncologia, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Candiolo, Italy., Hindi N; Instituto de Biomedicina (IBIS), Medical Oncology Department, Hospital Universitario Virgen del Rocio, Sevilla, Spain., Hug EB; MedAustron Ion Therapy Center, Wiener Neustadt, Austria., Jones R; Royal Marsden Hospital and Institute of Cancer Research, London, UK., Kawai A; Department of Musculoskeletal Oncology, National Cancer Center, Tokyo, Japan., Krol AD; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., Le Grange F; University College London Hospitals NHS Foundation Trust and the London Sarcoma Service, UK., Luzzati A; Centro di Chirurgia Ortopedica Oncologica e Ricostruttiva del Rachide, IRCCS Istituto Ortopedico Galeazzi, Milano, Italy., Marquina G; Department of Medical Oncology, Hospital Clinico San Carlos, Madrid, Spain., Martin-Benlloch JA; Department of Orthopaedic Surgery, Hospital Clinico Universitario de Valencia, Valencia, Spain., Mazzocco K; Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology, Department of Oncology and Hemato-Oncology, University of Milan, Milano, Lombardia, Italy., Navarria F; Department of Radiation Oncology, Centro di Riferimento Oncologico, National Cancer Institute, Aviano, Italy., Navarria P; Radiotherapy and Radiosurgery, Humanitas Clinical and Research Center, Rozzano, Milano, Italy., Parchi PD; 1st Orthopedic Division of Pisa University, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Patel S; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston, USA., Pennacchioli E; Division of Melanoma, Soft Tissue Sarcomas and Rare Tumors, European Institute of Oncology, Milan, Italy., Petrongari MG; Department of Radiation Oncology, Regina Elena National Cancer Institute, Rome, Italy., Picci P; Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy., Pollock R; Royal National Orthopaedic Hospital NHS Trust, Brockley Hill, Stanmore, Middlesex, UK., Porcu L; Laboratory of Methodology for Clinical Research, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Italy., Quagliuolo V; 1st Orthopedic Division of Pisa University, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Sangalli C; Department of Radiation Therapy, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Scheipl S; Department of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria., Scotto GM; Department of Medical Oncology, Hospital Clinico San Carlos, Madrid, Spain., Spalek M; Department of Radiotherapy I, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland., Steinmeier T; Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Center (WTZ), Germany., Timmermann B; Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Center (WTZ), German Cancer Consortium (DKTK), Germany., Trama A; Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy., Uhl M; Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany., Valverde C; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Varga PP; National Center for Spinal Disorders, Budapest, Hungary., Verges R; Radiation Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain., Weber DC; Centre for Proton Therapy, Paul Scherrer Institut, Villigen PSI, Switzerland., Zoccali C; Orthopedic Oncology Unit, Department of Experimental Clinical Oncology, Regina Elena National Cancer Institute, Rome, Italy., Casali PG; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy; Department of Medical Oncology and Haemato-Oncology, University of Milan, Milan, Italy., Sommer J; Chordoma Foundation, Durham, NC, USA., Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

المصدر: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2020 Aug; Vol. 46 (8), pp. 1415-1422. Date of Electronic Publication: 2020 Apr 27.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8504356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2157 (Electronic) Linking ISSN: 07487983 NLM ISO Abbreviation: Eur J Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Margins of Excision*, Chordoma/*radiotherapy , Chordoma/*surgery , Sacrum/*surgery, Humans ; Proton Therapy/adverse effects ; Radiotherapy Dosage

المؤلفون: Bosma SE; Department of Orthopedics, Leiden University Medical Center, Leiden, the Netherlands., Rueten-Budde AJ; Leiden University Mathematical Institute, Leiden, the Netherlands., Lancia C; Leiden University Mathematical Institute, Leiden, the Netherlands., Ranft A; University Hospital Essen, University Duisburg. Essen, Pediatrics III, Sarcoma Centre, West German Cancer Centre, German Cancer Consortium, Essen, Germany.; German Cancer Consortium (DKTK), Essen, Germany., Dirksen U; University Hospital Essen, University Duisburg. Essen, Pediatrics III, Sarcoma Centre, West German Cancer Centre, German Cancer Consortium, Essen, Germany.; German Cancer Consortium (DKTK), Essen, Germany., Krol AD; Department of Radiotherapy, Leiden University Medical Center, Leiden, the Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., van de Sande MAJ; Department of Orthopedics, Leiden University Medical Center, Leiden, the Netherlands., Dijkstra PDS; Department of Orthopedics, Leiden University Medical Center, Leiden, the Netherlands., Fiocco M; Leiden University Mathematical Institute, Leiden, the Netherlands.; Medical Statistics/Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.

المصدر: Pediatric blood & cancer [Pediatr Blood Cancer] 2019 Nov; Vol. 66 (11), pp. e27943. Date of Electronic Publication: 2019 Aug 06.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Models, Biological*, Bone Neoplasms/*pathology , Sarcoma, Ewing/*pathology, Adolescent ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bone Neoplasms/secondary ; Bone Neoplasms/therapy ; Child ; Child, Preschool ; Combined Modality Therapy ; Disease Progression ; Female ; Follow-Up Studies ; Humans ; Infant ; Infant, Newborn ; Kaplan-Meier Estimate ; Male ; Margins of Excision ; Neoplasm Metastasis ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm, Residual ; Proportional Hazards Models ; Retrospective Studies ; Risk Assessment ; Sarcoma, Ewing/secondary ; Sarcoma, Ewing/therapy

المؤلفون: van Eggermond AM; Department of Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands., Schaapveld M; Department of Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands.; Netherlands Comprehensive Cancer Organisation (IKNL), Hoog Catharijne, Godebaldkwartier 419, Utrecht 3511 DT, The Netherlands., Janus CP; Department of Radiation Oncology, Erasmus MC Cancer Institute, 's-Gravendijkwal 230, Rotterdam 3015 CE, The Netherlands., de Boer JP; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands., Krol AD; Division of Radiation Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333 ZA, The Netherlands., Zijlstra JM; Department of Hematology, VU University Medical Center, De Boelelaan 1117, Amsterdam 1081 HV, The Netherlands., van der Maazen RW; Department of Radiation Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, Nijmegen 6525 GA, The Netherlands., Kremer LC; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Meibergdreef 9, Amsterdam-Zuidoost 1105 AZ, The Netherlands., van Leerdam ME; Department of Gastroenterology and Hepatology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Louwman MW; Netherlands Comprehensive Cancer Organisation (IKNL), Hoog Catharijne, Godebaldkwartier 419, Utrecht 3511 DT, The Netherlands., Visser O; Netherlands Comprehensive Cancer Organisation (IKNL), Hoog Catharijne, Godebaldkwartier 419, Utrecht 3511 DT, The Netherlands., De Bruin ML; Department of Pharmacy, Faculty of Health and Medical Science (CORS), University of Copenhagen, Universitetsparken 2, Copenhagen 2100, Denmark., Aleman BM; Department of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands., van Leeuwen FE; Department of Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands.

المصدر: British journal of cancer [Br J Cancer] 2017 Jul 25; Vol. 117 (3), pp. 306-314. Date of Electronic Publication: 2017 Jun 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Colon*, Antineoplastic Agents/*administration & dosage , Colorectal Neoplasms/*epidemiology , Hodgkin Disease/*drug therapy , Hodgkin Disease/*radiotherapy , Neoplasms, Radiation-Induced/*epidemiology , Neoplasms, Second Primary/*epidemiology , Procarbazine/*administration & dosage, Adult ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bleomycin/therapeutic use ; Colorectal Neoplasms/etiology ; Diaphragm ; Doxorubicin/therapeutic use ; Female ; Follow-Up Studies ; Humans ; Male ; Mechlorethamine/therapeutic use ; Middle Aged ; Neoplasms, Radiation-Induced/etiology ; Neoplasms, Second Primary/etiology ; Netherlands/epidemiology ; Prednisone/therapeutic use ; Procarbazine/therapeutic use ; Rectum ; Risk Factors ; Survivors ; Vinblastine/therapeutic use ; Vincristine/therapeutic use ; Young Adult

SCR Protocol: MOPP protocol; MOPP-ABV protocol